RNAi Therapeutics: How Likely, How Soon?
Open Access
- 20 January 2004
- journal article
- other
- Published by Public Library of Science (PLoS) in PLoS Biology
- Vol. 2 (1) , e28-E28
- https://doi.org/10.1371/journal.pbio.0020028
Abstract
RNA interference (RNAi) is used in the lab to silence virtually any gene. Previously, antisense and ribozymes were successful in the lab, but have been disappointing in the clinic. Will RNAi succeed where these two have not?Keywords
This publication has 5 references indexed in Scilit:
- RNA interference targeting Fas protects mice from fulminant hepatitisNature Medicine, 2003
- Small RNAs Make Big SplashPublished by American Association for the Advancement of Science (AAAS) ,2002
- A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with aids11InternetAdvance publication at ajo.com Feb 8, 2002.Financial disclosures and conflict of interest statements are listed at the end of the article.Reprint requests to René Lanz, PhD, Novartis Ophthalmics AG, Grenzstrasse 10, CH-8180 Bülach, Switzerland; fax: (41) 1-862-0762; e-mail: rene.lanz@pharma.novartis.comCorrespondence to Stephen L. Hutcherson, MBA, Cyclix Ltd. LLC, 11851 Rexmoor Drive, Richmond, VA 23236; fax: (804) 897-9544; e-mail: cyclix@comcast.netAmerican Journal of Ophthalmology, 2002
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995